DF Logo

Welcome Guest ( Log In | Register )

Advertisement


 
Reply to this topicStart new topic
>  New Weight-Loss Drug Shows Promise, Contrave users lost 7 percent of weight in 6 months, study found | Add To Bookmarks
Advertisement
Advertisement
Forum Admin
post Sep 29 2006, 02:11 PM
Post #1


Admin Team
Group Icon


Group: Super Administrators
Posts: 10,700
Joined: 15-June 04
From: United States
Member No.: 4




QUOTE
FRIDAY, Sept. 29 (HealthDay News) -- Patients taking an investigational weight-loss drug called Contrave lost an average of more than 7 percent of their weight in the first 24 weeks of a phase III clinical trial, according to interim findings released this week by the company that developed the drug.

The study was expected to continue for another 24 weeks.

Contrave is a combination of two drugs -- naltrexone (already used to treat opium addiction withdrawal) and bupropion (used to treat depression and to help people quit smoking). Contrave is intended to affect a person's craving for food and the body's regulation of energy.

"Contrave is designed to activate a hypothalmic center in the brain associated with reduced appetite, while blocking beta-endorphin, which may be responsible for limiting weight loss," Dr. Gary Tollefson, president and CEO of Orexigen Therapeutics Inc., said in a prepared statement. "We are also studying the effects of Contrave on related central pathways associated with the rewarding nature of select high-calorie foods."


Read More.....










SOURCE: Orexigen Therapeutics Inc., news release, Sept. 26, 2006


--------------------
~Lindsay, Forum Super Administrator, Founder



Hotlines
Go to the top of the page
 
+Quote Post

24&mustangs
post Dec 18 2006, 10:58 AM
Post #2


Member
***


Group: Member
Posts: 230
Joined: 13-March 06
From: TN
Member No.: 6,335




QUOTE(Forum Admin @ Sep 29 2006, 01:11 PM) *
QUOTE
FRIDAY, Sept. 29 (HealthDay News) -- Patients taking an investigational weight-loss drug called Contrave lost an average of more than 7 percent of their weight in the first 24 weeks of a phase III clinical trial, according to interim findings released this week by the company that developed the drug.

The study was expected to continue for another 24 weeks.

Contrave is a combination of two drugs -- naltrexone (already used to treat opium addiction withdrawal) and bupropion (used to treat depression and to help people quit smoking). Contrave is intended to affect a person's craving for food and the body's regulation of energy.

"Contrave is designed to activate a hypothalmic center in the brain associated with reduced appetite, while blocking beta-endorphin, which may be responsible for limiting weight loss," Dr. Gary Tollefson, president and CEO of Orexigen Therapeutics Inc., said in a prepared statement. "We are also studying the effects of Contrave on related central pathways associated with the rewarding nature of select high-calorie foods."


Read More.....




Yeah!!! Coopclapping.gif I hope it's on the market soon. I'll take all the help I can get.









SOURCE: Orexigen Therapeutics Inc., news release, Sept. 26, 2006
Go to the top of the page
 
+Quote Post

jabberjaws
post Dec 18 2006, 11:23 AM
Post #3


Advanced Member
****


Group: Advanced Member
Posts: 306
Joined: 29-November 06
From: WI
Member No.: 12,082




Sounds like something I sure could use. I'm trying to exercise but I just can't keep on a regular schedule. But doing both might just work. I hope it comes out soon. I wonder if this is going to be a over the counter drug. But I bet you'll need a prescription.
Go to the top of the page
 
+Quote Post


Reply to this topicStart new topic
1 User(s) are reading this topic (1 Guests and 0 Anonymous Users)
0 Members:


 

RSS Lo-Fi Version Time is now: 21st November 2009 - 01:03 AM